ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.
Ovarian Cancer|Adnexal Mass
DRUG: Method 1: Indocyanine green dye|DRUG: Method 2: Indocyanine green dye|DRUG: Method 3: Indocyanine green dye|DRUG: Method 3: Indocyanine green dye
Number and location of ovarian sentinel lymph nodes visually identified after injection of ICG dye via one of three tested methods., Evaluate for dye uptake in the regional lymphatic channels, and in the pelvic and para-aortic nodes using infrared imaging., 1 year
The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.